We are live on ! Find out more
NEI

Northwest & Ethical Investments Portfolio holdings

AUM $4.32B
1-Year Est. Return 23.26%
This Fund
S&P 500
This Quarter Est. Return
-2.95%
1 Year Est. Return
+23.26%
3 Year Est. Return
+66.45%
5 Year Est. Return
+83.35%
10 Year Est. Return
+281.09%
AUM
$1.49B
AUM Growth
-$49.7M
Cap. Flow
+$3.33M
Cap. Flow %
0.22%
Top 10 Hldgs %
19.67%
Holding
378
New
31
Increased
128
Reduced
132
Closed
27

Top Sells

Rank Stock Value
1
AGU
Agrium
AGU
+$20.5M
2
RBA icon
RB Global
RBA
+$16.7M
3
POT
Potash Corp Of Saskatchewan
POT
+$5.52M
4
MSFT icon
Microsoft
MSFT
+$5.5M
5
SU icon
Suncor Energy
SU
+$5.17M

Sector Composition

Rank Sector Weight
1 Financials 24.68%
2 Industrials 12.9%
3 Technology 9.74%
4 Consumer Discretionary 9.61%
5 Healthcare 8.67%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FBIN icon
326
Fortune Brands Innovations
FBIN
$6.06B
$165K 0.01%
3,276
+702
+27% +$39.1K
MTN icon
327
Vail Resorts
MTN
$5.3B
$164K 0.01%
738
+100
+16% +$21.9K
LM
328
DELISTED
Legg Mason, Inc.
LM
$163K 0.01%
4,000
+700
+21% +$28.9K
JBLU icon
329
JetBlue
JBLU
$2.29B
$161K 0.01%
7,900
+1,700
+27% +$36.1K
MDT icon
330
Medtronic
MDT
$112B
$152K 0.01%
1,900
BIO icon
331
Bio-Rad Laboratories Class A
BIO
$9.42B
$150K 0.01%
+600
New +$153K
HRC
332
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$148K 0.01%
+1,700
New +$145K
NVRO
333
DELISTED
NEVRO CORP.
NVRO
$147K 0.01%
1,700
+400
+31% +$32.3K
TXRH icon
334
Texas Roadhouse
TXRH
$13.7B
$144K 0.01%
2,500
-400
-14% -$23K
EW icon
335
Edwards Lifesciences
EW
$51.7B
$143K 0.01%
3,075
THO icon
336
Thor Industries
THO
$4.14B
$138K 0.01%
1,200
+200
+20% +$26.7K
PJT icon
337
PJT Partners
PJT
$4.38B
$130K 0.01%
2,593
BID
338
DELISTED
Sotheby's
BID
$118K 0.01%
+2,300
New +$117K
ABMD
339
DELISTED
Abiomed Inc
ABMD
$116K 0.01%
400
-300
-43% -$76K
H icon
340
Hyatt Hotels
H
$16.7B
$114K 0.01%
1,500
-800
-35% -$62.8K
JAZZ icon
341
Jazz Pharmaceuticals
JAZZ
$16.7B
$106K 0.01%
+700
New +$103K
ISRG icon
342
Intuitive Surgical
ISRG
$134B
$104K 0.01%
756
BMRN icon
343
BioMarin Pharmaceuticals
BMRN
$12.4B
$97.3K 0.01%
1,200
+400
+50% +$34.3K
NBIX icon
344
Neurocrine Biosciences
NBIX
$16.6B
$91.2K 0.01%
+1,100
New +$92.9K
ATTO
345
DELISTED
Atento S.A.
ATTO
$86.3K 0.01%
2,202
BIIB icon
346
Biogen
BIIB
$30.7B
$82.1K 0.01%
300
CELG
347
DELISTED
Celgene Corp
CELG
$80.3K 0.01%
900
-11,255
-93% -$1.08M
INCY icon
348
Incyte
INCY
$24.4B
$79.7K 0.01%
956
+200
+26% +$18K
ALGN icon
349
Align Technology
ALGN
$12.3B
$74.8K 0.01%
298
CLVS
350
DELISTED
Clovis Oncology, Inc.
CLVS
$73.9K 0.01%
+1,400
New +$81.7K

Similar funds

Northwest & Ethical Investments's Q1 2018 Portfolio in Review

As of Q1 2018, Northwest & Ethical Investments held 378 positions worth $1.49B, down 3.2% from $1.54B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Northwest & Ethical Investments's Q1 2018 filing shows 31 new, 128 increased, 132 reduced and 27 closed positions. Its largest new stake was Nutrien: 489,505 shares worth $23.1M. The largest sale was Agrium, an estimated $20.5M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 25% a quarter earlier, followed by Industrials and Technology.

  • Northwest & Ethical Investments's largest Q1 2018 buy was Nutrien: 489,505 shares worth $23.1M.
  • Northwest & Ethical Investments added most to Cenovus Energy in Q1 2018, an estimated $13.7M increase.
  • Northwest & Ethical Investments's biggest Q1 2018 reduction was RB Global, cutting an estimated $16.7M.
  • Northwest & Ethical Investments fully exited Agrium in Q1 2018, selling an estimated $20.5M.
  • Northwest & Ethical Investments's ten largest holdings make up 20% of its $1.49B portfolio in Q1 2018.
  • Northwest & Ethical Investments opened 31 new positions and closed 27 in Q1 2018.
  • Northwest & Ethical Investments's portfolio value fell 3.2% quarter-over-quarter to $1.49B.

Based on Northwest & Ethical Investments's 13F filing for Q1 2018, filed 8 Jul 2025.